Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Summary
The bill amends the Controlled Substances Act to classify synthetic 7‑hydroxymitragynine and its synthetic equivalents as a Schedule I drug, the most restrictive category. It specifically excludes the naturally occurring form of the compound that is found in the kratom plant. This change aims to curb the distribution of the synthetic version while leaving kratom itself untouched.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HR 8000 changes status, plus AI-powered summaries and stage predictions.
Sign up free